NDC 69911-475

NDC codes

FDA NDC Directory

Product NDC (as listed)69911-475Labeler and product segments. Claims need a package NDC.

Product NDC at billing width69911-0475Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
69911-475-02	69911047502	1 KIT in 1 CARTON (69911-475-02) * 2.5 mL in 1 VIAL, SINGLE-USE (69911-765-83) * 2.5 mL in 1 VIAL, SINGLE-USE (69911-485-01)Marketed from May 25, 2016

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): AFSTYLA Antihemophilic Factor (Recombinant), Single ChainSuffix: Antihemophilic Factor (Recombinant), Single Chain
Generic name (nonproprietary): antihemophilic factor, human recombinant
Dosage form: Kit
Labeler: CSL Behring Lengnau AG
Product type: Plasma derivative
Marketing category: BLA — Biologics License ApplicationApplication BLA 125591
Marketing start: May 25, 2016
Listing expires: Dec 31, 2026
Identifiers: Product ID 69911-475_757ccd2f-85b7-440f-905f-b999e2d1dd4bSPL ID 757ccd2f-85b7-440f-905f-b999e2d1dd4b

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

NDC on a medical claim

N469911047502 followed by a unit qualifier and the quantity

Package 69911-0475-02. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

The FDA listing for this product does not reference a label (SPL) set.

Other NDCs under BLA 125591

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under BLA 125591
Product	Strength	Form · route	Labeler	Product NDC
AFSTYLA Antihemophilic Factor (Recombinant), Single Chainantihemophilic factor, human recombinant	—	Kit	CSL Behring Lengnau AG	69911-481
AFSTYLA Antihemophilic Factor (Recombinant), Single Chainantihemophilic factor, human recombinant	—	Kit	CSL Behring Lengnau AG	69911-474
AFSTYLA Antihemophilic Factor (Recombinant), Single Chainantihemophilic factor, human recombinant	—	Kit	CSL Behring Lengnau AG	69911-480
AFSTYLA Antihemophilic Factor (Recombinant), Single Chainantihemophilic factor, human recombinant	—	Kit	CSL Behring Lengnau AG	69911-476
AFSTYLA Antihemophilic Factor (Recombinant), Single Chainantihemophilic factor, human recombinant	—	Kit	CSL Behring Lengnau AG	69911-477
AFSTYLA Antihemophilic Factor (Recombinant), Single Chainantihemophilic factor, human recombinant	—	Kit	CSL Behring Lengnau AG	69911-478

AFSTYLA Antihemophilic Factor (Recombinant), Single Chain NDC 69911-475